VC firms

Senior Scientist / Scientist, Cell-Based Assays & Immunology

C10 Labs · Cambridge · On-site

← All jobs
About C10 Labs

C10 Labs is an AI venture fund and studio building category-defining AI companies from Cambridge and NYC. Explore our accelerator programs, portfolio, and team.

About the role

Noara Therapeutics is an early-stage, stealth biotechnology company developing next-generation RNA-LNP-based cell therapies for the treatment of autoimmune diseases, cancer, and other chronic conditions. Our platform integrates synthetic biology, RNA engineering, machine learning, and high-throughput experimentation to create durable, effective therapies with reduced immunotoxicity.

More about this role

About Noara Therapeutics

Noara Therapeutics is an early-stage, stealth biotechnology company developing next-generation RNA-LNP-based cell therapies for the treatment of autoimmune diseases, cancer, and other chronic conditions. Our platform integrates synthetic biology, RNA engineering, machine learning, and high-throughput experimentation to create durable, effective therapies with reduced immunotoxicity. As a growing startup, we offer a collaborative, fast-paced environment where every team member has a direct impact on scientific strategy and company success. We are seeking a highly motivated scientist to lead the development and execution of cell-based and immunology assays that will guide therapeutic discovery and development.

Position Summary

We are seeking an experienced Senior Scientist or Scientist with deep expertise in cell biology, immunology, and assay development. This is a laboratory-based role with significant opportunities to influence experimental strategy, establish new capabilities, and contribute to the scientific direction of our platform.

The successful candidate will work closely with colleagues across molecular biology, computational biology, automation,...

Read the full posting on C10 Labs's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.